Direct-current shock in the treatment of cardiac arrhythmias. A clinical study.
D000328:Adult; D000367:Age Factors; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000628:therapy*; D001219:Aspartate Aminotransferases / Q000097:blood; D001281:Atrial Fibrillation / Q000628:therapy; D001282:Atrial Flutter / Q000628:therapy; D003402:Creatine Kinase / Q000097:blood; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004554:Electric Countershock; D004562:Electrocardiography; D005260:Female; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D006873:Hydroquinones / Q000627:therapeutic use; D008297:Male; D008722:Methods; D008875:Middle Aged; D011379:Prognosis; D013223:Statistics as Topic; D013610:Tachycardia / Q000628:therapy; D014693:Ventricular Fibrillation / Q000628:therapy
D004071:Digitalis Glycosides; D006873:Hydroquinones; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase